Press release
2nd World Congress on Epilepsy and Brain Disorders
Epilepsy Congress 2019
The main theme of the Epilepsy Congress 2019 is ‘’ Elimination of Epilepsy’’ which has the following Tracks/ Sessions:
•Epilepsy
•Chronic Disorder
•Neurological Disorder
•Seizure Disorders
•Psychiatric Disorders
•Drug Delivery to Epilepsy Brain
And many more interesting sessions.
Epilepsy Meetings welcomes you at 2nd World Congress on Epilepsy and Brain Disorders going to be held at Helsinki, Finland during June 13-14, 2019 which joins brief keynote introductions, speaker talks, displays, Symposiums, workshops, Technical discussion on Neuroscience.
Address: 47 Churchfield Road, London W36AY, UNITED KINGDOM
+442088190774
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2nd World Congress on Epilepsy and Brain Disorders here
News-ID: 1473194 • Views: …
More Releases from ME Conferences
10th European Epidemiology and Public Health Congress
Euro Epidemiology Conference 2020 will focus on the latest and exciting innovations in all areas of Epidemiology and Public Health which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme,“ Exploring the emerging transitions in Epidemiology and Public Health ” which reflects the innovative progress in Epidemiology and Public health.
The two days conference includes workshops,…
You’re running out of time! Start your Journey to Amsterdam for a good cause!
Numerous individuals with epilepsy have more than one sort of seizure and may have different side effects of neurological issues also. Some of the time EEG (electroencephalogram) testing, clinical history, family ancestry, and standpoint are comparable among a gathering of individuals with epilepsy. In these circumstances, their condition can be characterized as a particular epilepsy disorder.
So, let’s look forward to gaining knowledge on Epilepsy, and Brain Disorders Care at "2nd…
More Releases for Epilepsy
Portable Epilepsy Monitoring Market in 2025
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Portable Epilepsy Monitoring Market- (By Product Type (Device Type (Chest Sensor, Watch Sensor, Monitors, Cameras, Mattresses and Pillows, and Others) and Service), By End User (Hospitals, Ambulatory Surgery Centres & Clinics, Neurology Centres, and Home Care Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global…
Top 10 Epilepsy Companies Analysis (2024)
Epilepsy also known as seizure disorder, is a chronic noncommunicable disease that affects brain. Epilepsy affects people of all races, ethnic backgrounds, genders, and ages.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00016405/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Epilepsy Market are:
• Idexx Laboratories Inc.
• PBD Biotech Ltd
• Thermo Fisher Scientific Inc.
• Innovative Diagnostics SAS
• Neogen Corp
• Enfer Labs
• bioMerieux SA
• Ring Biotechnology Co Ltd
• Bionote Inc.
• Shenzhen Bioeasy Biotechnology Co Ltd.
Contact Us:
If you have any queries about this report or if…
Epilepsy Market: Trends, Opportunities, and Challenges
Epilepsy is a neurological disorder characterized by recurrent seizures, which are caused by abnormal electrical activity in the brain. This condition affects millions of people globally, making it one of the most common neurological disorders. As the global burden of epilepsy increases, the demand for effective treatments and solutions continues to grow. The epilepsy market is evolving rapidly, with advancements in medication, diagnostics, and therapeutic technologies. This guest post aims…
Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 …
The global epilepsy devices market isx experiencing a remarkable surge, poised to exceed a valuation of $1.1 billion by 2031, as revealed by the latest market analysis. According to the report released by Allied Market Research, the market was valued at $675.23 million in 2021 and is projected to grow at a CAGR of 5.1% from 2022 to 2031.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://www.alliedmarketresearch.com/request-sample/A14821
Epilepsy devices play…
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market - Breaking the Sei …
Newark, New Castle, USA: The "Epilepsy with Myoclonic-Atonic Seizures Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market: https://www.growthplusreports.com/report/epilepsy-with-myoclonic-atonic-seizures-therapeutics-market/8029
This…
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy …
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curve…
